Without a rigorous discussion of the pros and cons of QbD, its tremendous benefits will be lost.
Lynn Torbeck
Advertisement
Lynn Torbeck is a statistician at Torbeck and Assoc.
Articles by Lynn Torbeck
Advertisement
Latest Updated Articles
QbD: Convincing the SkepticsPublished: May 1st 2009 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Applying Analytical Quality by Design Principles to Biopharma Method Development and Optimization
2
CPHI Frankfurt 2025 Highlights Global Pharma Innovation and Manufacturing Leadership
3
Why Radiopharmaceuticals Are Ideal for Treating Cancer
4
AstraZeneca Lupus Treatment Support in EU Opens Door for Self-Administration Options
5
